Idexx Earnings Easily Beat With Stock Near Buy Point

Early Tuesday, Idexx Laboratories (IDXX) reported adjusted earnings of $2.35 per share on $7.78 million in sales for its first quarter. Idexx stock was not yet active.


On average, analysts polled by FactSet expected Idexx to earn $1.71 per share on $738.4 million in sales.

In the year-ago period, Idexx earnings were $1.29 per share and the animal diagnostics player had $626.3 million in sales.

For the year, Idexx guided to EPS of $7.88-$8.18 with revenue of $3.105 billion to $3.16 billion. Analysts called for Idexx earnings of $7.57 per share and $3.1 billion in sales.

In premarket trading on the stock market today, Idexx stock was not yet trading after closing Monday at 549.88. Idexx stock is forming a cup-with-handle base with a buy point at 561.62, according to

Idexx Labs is on the IBD Long-Term Leaders List.

More to follow.

Follow Allison Gatlin on Twitter at @IBD_AGatlin.


Vaxart Stock Plummets On Growing Losses As Investors Eye Covid Pill

Vaccine Hesitancy Ticks Down — Here’s What That Means For Covid Stocks

Learn How To Time The Market With IBD’s ETF Market Strategy

Options Trading: How To Start Using Options, How To Manage Risk

Get Timely Buy & Sell Alerts With IBD Leaderboard

Most Related Links :
usnewsmail Governmental News Finance News

Source link

Back to top button